Singapore markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7205-0.0195 (-2.64%)
As of 11:21AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.7400
Open0.7035
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.7000 - 0.7400
52-week range0.6520 - 11.9100
Volume4,916
Avg. volume57,093
Market cap4.948M
Beta (5Y monthly)0.02
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    Insiders Are Buying These 11 Penny Stocks

    In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5 Penny Stocks. US stock market started the second quarter of 2024 in the red, driven by rising treasury yields, broader volatility and uncertainty around rate cuts […]

  • Benzinga

    EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year

    Alzamend Neuro Inc (NASDAQ: ALZN) received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for post-traumatic stress disorder (PTSD). "Although lithium does not have an FDA-approved indication for PTSD, it has been prescribed off-label for this purpose for decades," said Stephan Jackman, Chief Executive Officer of Alzamend. "If we can develop a next-generation lithium product (AL001) that would not routinely require therapeutic drug m